Holen Sie sich die Stockscreener-App
67.60
0.82%
-0.56
Vorhandelsmarkt:
67.76
0.16
+0.24%
Schlusskurs vom Vortag:
$68.16
Offen:
$68.46
24-Stunden-Volumen:
1.40M
Relative Volume:
0.78
Marktkapitalisierung:
$3.59B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-22.56
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
+18.91%
1M Leistung:
-0.10%
6M Leistung:
-5.39%
1J Leistung:
+33.89%
1-Tages-Spanne:
$65.97
$68.46
1-Wochen-Bereich:
$61.00
$68.46
52-Wochen-Spanne:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
Soleno Therapeutics Inc
Sektor
Branche
Telefon
650-213-8444
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Vergleichen Sie SLNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
67.60 | 3.62B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-23 | Eingeleitet | TD Cowen | Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2024-12-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-12-02 | Bestätigt | Stifel | Buy |
| 2024-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-23 | Eingeleitet | Stifel | Buy |
| 2023-11-21 | Fortgesetzt | Guggenheim | Buy |
| 2020-09-29 | Eingeleitet | Guggenheim | Buy |
| 2020-01-10 | Eingeleitet | Craig Hallum | Buy |
| 2019-12-23 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Will Soleno Therapeutics Inc. (6XC) stock justify high valuationMarket Performance Report & Long-Term Capital Growth Strategies - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - PR Newswire
How to escape a deep drawdown in Soleno Therapeutics Inc.Weekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Insider Monkey
What Wall Street predicts for Soleno Therapeutics Inc. stock priceRecession Risk & AI Forecast Swing Trade Picks - newser.com
Can Soleno Therapeutics Inc. stock deliver sustainable ROEEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Detecting support and resistance levels for Soleno Therapeutics Inc.2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
How Soleno Therapeutics Inc. (6XC) stock stacks up against competitors2025 Market Outlook & Smart Money Movement Tracker - newser.com
Is Soleno Therapeutics Inc. stock supported by strong cash flows2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
How Soleno Therapeutics Inc. stock performs in rate cut cycles2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Momentum divergence signals in Soleno Therapeutics Inc. chartMarket Activity Recap & Safe Entry Trade Reports - newser.com
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - WV News
Soleno Therapeutics Insiders Sold US$23m Of Shares Suggesting Hesitancy - 富途牛牛
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
What analysts say about Soleno Therapeutics Inc stockTrading Volume Surges & Explore Stocks for Free with Our Research Portal - Early Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure - Investing.com Canada
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure By Investing.com - Investing.com South Africa
SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire Inc.
Wells Fargo Sticks to Their Buy Rating for Soleno Therapeutics (SLNO) - The Globe and Mail
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):